Healthcare Services Investment Banks Rankings

What are the best Healthcare Services Middle Market Investment Banks (excluding biotech)?

Rank the firms: William Blair, Houlihan Lokey, Wells Fargo, Raymond James, TripleTree, Harris Williams, Suntrust, Stifel, Baird, Lincoln International.

I think it goes tier in order of names: 1: HL, WB, HW, TripleTree (pure play), Cain Brothers (pure play) 2: Lincoln International, Wells Fargo, Raymond James, Baird, BMO, SunTrust, Stifel

67 Comments
 

MTS does do healthcare services work and it is one of their stated focuses, but I think they have been more successful in the life sciences space as of late. They're also moving on an upward trajectory, so I would not be surprised if they started running more HC services m&a down the road.

Leerink is, as you said, biopharma and ECM focused. If you're interested in that, they're top tier.

Dayman?
 

Idk where you heard cantor only doing biotech. They do every vertical within healthcare. Biotech, biopharma, healthcare services, even healthcare REITS. I’d include them in your tier 1 after Sage brought over all the Jefferies folks

Array
 

@OP I know that your post says middle market, but from your perspective did you include all of Wells Fargo Healthcare Services in your ranking or just the middle market portion of the firm?

Array
 

Right, but Wells also has a middle-market unit (but probably not well known/strong). But based on your response I am guessing you meant their regular healthcare services arm.

Array
 
Most Helpful

Tier 1: Jefferies, WB, Cain, HW, Piper, HL

Tier 2: TT, Baird, Lincoln, Cowen, BMO, Lazard MM, Ray Jay

Boutiques: Coker, Brentwood (few I am forgetting)

FWIW, there is a ton of shuffling going on in MM HC. Cain just lost a couple key services MDs, TT is trying to really grow its services segment, but is known more for HCIT and has a mixed reputation, BMO lost some guys.

 

As a former Cain Brothers client, I'd recommend them. Their tone has changed a bit since the KeyBank acquisition, but they still know how to find and source deals.

If looking for DCM, Cain does well...but Ponder & Co. seems to service all of the large Health Systems. Wells also has a strong team in Philly on the healthcare side.

For boutiques, CapstoneHeadwaters led a couple of sell-side deals in the area recently that garnered eye-popping returns (aka stupid multiples I wouldn't even pay when drunk).

Have heard good things about Ziegler but have never worked with them directly.

Director of Finance and Corporate Development: 2020 - Present Manager of FP&A and Corporate Development: 2019 - 2020 Corporate Finance, Strategy and Development: 2011 - 2019 "An investment in knowledge pays the best interest." - Benjamin Franklin
 
"1st Year Associate in Private Equity - LBOs " Echoing your comment on CapstoneHeadwaters. They've sent over a few teasers for niche healthcare service companies. We pursued one but couldn't bring ourselves to bid upwards of ~14x EBITDA.

Have never heard of these guys being competitive in the MM, but to your points, they seem to have one HC MD that is just crushing it the past couple of years.

 

I seem to be a lot of mentions regarding TT as of late - curious what your updated view is regarding them (lateral if it makes a difference)?

 

Impedit aut tempore et magnam consequatur. Consequatur a quae rerum occaecati vero. Velit nisi sapiente eaque doloribus eum sunt rerum.

 

Laudantium sint sequi quas sequi. Commodi et at voluptatem fugit omnis deleniti dolorum voluptas. Ipsa error sunt fuga perferendis. Animi quis asperiores sint ut maxime amet eum. Est maiores et sunt nostrum. Cumque at eligendi aspernatur est fuga voluptatem ut. Ullam atque hic sit natus placeat debitis.

Vero voluptas sit omnis reiciendis minus et quibusdam. Earum dolores labore quia odit et. Aut ut eligendi iusto ex. Rerum voluptatem quod perspiciatis eligendi temporibus nisi.

Nam nemo fuga et soluta quas ut reiciendis. Iusto voluptatem quia et blanditiis. Mollitia ea voluptatem ducimus sit et.

Aliquam quas itaque cumque ex quis voluptatem officia soluta. Aliquid est ut aut sint eius minus autem. Et nisi quas et ut. Doloribus et blanditiis exercitationem rerum nostrum ea. Quia numquam ut ut.

 

Eaque in velit at dolores minus impedit delectus. Sint maiores et voluptate aspernatur odit doloremque unde. Et enim vel expedita soluta adipisci. Eum est dignissimos amet exercitationem distinctio. Quis in qui rem quod et. Laboriosam quo adipisci ut unde eos iusto. Et libero provident optio quos praesentium et.

Error eius voluptatem dicta corrupti ut. Et laudantium reprehenderit architecto ad deserunt esse excepturi dolorum. Sapiente blanditiis nihil qui ipsum velit assumenda non. Sit et non harum facere ut quidem eum.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”